Home / Conferences / Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference Posted 09/03/2018

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference
13−15 June 2018
Hilton Budapest Hotel
Budapest
Hungary

The Joint 24th Medicines for Europe and 21st IGBA Annual Conference will bring together over 300 experts including medicine manufacturers, stakeholders and governments to evaluate market trends, innovative commercial strategies, challenges for the pharmaceutical sector and new opportunities to improve access to medicines for patients. At this unique event, participants will have the opportunity to:

* get updates on the latest development and market trends in the Generic, Biosimilar and Value Added Medicines industry
* meet high-level speakers from Europe, Brazil, US, Japan, Taiwan, Russia, Canada, Malaysia, South Africa, India and many more countries to understand the global relevance of Generic, Biosimilar and Value Added Medicines
* network with policymakers, regulators, payers and peers
* discover business opportunities in pharmaceutical markets across the world

And finally have the opportunity to network in the beautiful capital of Hungary, Budapest!

www.medicinesforeurope.com/events/annual2018

Comments (0)